about-us

Lung in Vitro Model Market is Expected to Grow with a CAGR of 17.1% from 2022 to 2028

As stated in our extensive report, providing insights on Type, and Application; the Global Lung in Vitro Model  Market accounted for USD 275.1 Million in 2021.

In vitro models play an important role in biology and medicine. It provides the perception of cells and microorganisms' behavior. In addition, various advancement has been made in this model like organ and chip system to develop organs accordingly. Various cell lines are used for lungs such as Calu-3, NHBE, A549, and 16HBE. Furthermore, rising attention to the development of animal model alternatives, advancement in cell culture technology, and the development of new 3D in vitro models are some of the major parameters in spurring the growth of Lung in Vitro Model Market in recent years.

Factor such as increasing occurrences of lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), asthma, and lung cancer is propelling the growth of Lung in Vitro Model Market in coming years. In addition, stringent regulations to minimize animal experimenting are also expected to propel the growth of Lung in Vitro Model Market over the projected year.

Lungs are a very important organ in the human body and dysfunctioning of this organ creates great damage. In vitro model is used in drug screening and provide better alternatives for reducing experiments on animals. It is also used to address the introduction of 3D in research methods to reproduce human tissues. Thus, various leading players are started introducing new products in the market to grow their business. For instance, BICO, a bio-convergence startup that designs and supplies technologies and services, launched a 3D Bio-printing contract research offering from CELLINK, MatTek, and Visikol. The three companies have joined forces to present customers with a first-of-its-kind full-service 3D bio-manufacturing and in vitro analysis service.

 

Rising research projects on lung disorders, the emergence of advanced 3D in vitro models, and rising adoption of 3D cell culture are some major factors that influence the growth of Lung in Vitro Model Market during projected years. The major consumer of Lung in Vitro Model is research organizations & academics, government research institutes, life-science companies, and biotechnology & pharmaceutical companies. The high usage of this model in various organizations is accelerating the growth of Lung in Vitro Model Market in upcoming years. For instance, InSphero AG, an innovator and a provider of 3D cell-based platforms, have received USD 10 million for their research on discovery platforms for cancer and metabolic diseases.

North America accounted largest share of Lung in Vitro Model market during forecast period. Rising research activities, supportive healthcare policies, maximum investments for new product development, and favorable government initiatives are expected to drive the Lung in Vitro Model market demand in this region. In addition, the large presence of market players established healthcare infrastructure, and growing animal welfare regulations & related awareness programs are some of the key factors that bolstered the growth of the Lung in Vitro Model Market in this region.

Some of the prominent players operating in the Global Lung in Vitro Model Market are Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK)..